BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

281 related articles for article (PubMed ID: 3553617)

  • 1. Physiology of erection and pharmacological management of impotence.
    Lue TF; Tanagho EA
    J Urol; 1987 May; 137(5):829-36. PubMed ID: 3553617
    [No Abstract]   [Full Text] [Related]  

  • 2. Pharmacological erection: diagnosis and treatment applications in 69 patients.
    Nellans RE; Ellis LR; Kramer-Levien D
    J Urol; 1987 Jul; 138(1):52-4. PubMed ID: 2439712
    [TBL] [Abstract][Full Text] [Related]  

  • 3. How safe is the treatment of impotence with intracavernous autoinjection?
    Zentgraf M; Ludwig G; Ziegler M
    Eur Urol; 1989; 16(3):165-71. PubMed ID: 2663519
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Intracavernous injection of vasoactive drugs, an alternative for treating impotence in spinal cord injury patients.
    Wyndaele JJ; de Meyer JM; de Sy WA; Claessens H
    Paraplegia; 1986 Oct; 24(5):271-5. PubMed ID: 3774363
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Priapism: an avoidable complication of pharmacologically induced erection.
    Fouda A; Hassouna M; Beddoe E; Kalogeropoulos D; Binik YM; Elhilali MM
    J Urol; 1989 Oct; 142(4):995-7. PubMed ID: 2795759
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Risks of self-injection therapy for impotence.
    Millard RJ; Stricker PD; Lynch WJ; Dean TE; Murnaghan GF; Breslin FH
    Med J Aust; 1996 Jul; 165(2):117-8. PubMed ID: 8692055
    [No Abstract]   [Full Text] [Related]  

  • 7. Diagnostic and therapeutic technology assessment. Vasoactive intracavernous pharmacotherapy for impotence: papaverine and phentolamine.
    JAMA; 1990 Aug; 264(6):752-4. PubMed ID: 2374280
    [No Abstract]   [Full Text] [Related]  

  • 8. Fibrosis of tunica albuginea: complication of long-term intracavernous pharmacological self-injection.
    Hu KN; Burks C; Christy WC
    J Urol; 1987 Aug; 138(2):404-5. PubMed ID: 2439714
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Treatment of persistent penile erection and priapism using terbutaline.
    Shantha TR; Finnerty DP; Rodriquez AP
    J Urol; 1989 Jun; 141(6):1427-9. PubMed ID: 2724442
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pharmacologic erection program for the treatment of male impotence.
    Trapp JD
    South Med J; 1987 Apr; 80(4):426-7. PubMed ID: 2436316
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Therapeutic roles of intracavernosal papaverine.
    Goldstein I; Payton T; Padma-Nathan H
    Cardiovasc Intervent Radiol; 1988 Aug; 11(4):237-9. PubMed ID: 3147138
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Intracavernous self-injection pharmacotherapy program: analysis of results and complications.
    Valdevenito R; Melman A
    Int J Impot Res; 1994 Jun; 6(2):81-91. PubMed ID: 7951702
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Physiological considerations in radionuclide imaging of the penis during impotence therapy.
    Chaudhuri TK; Fink S; Burger RH; Netto IC; Palmer JD
    Am J Physiol Imaging; 1989; 4(2):75-80. PubMed ID: 2667586
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Treatment of prolonged or priapistic erections following intracavernosal papaverine therapy.
    Padma-Nathan H; Goldstein I; Krane RJ
    Semin Urol; 1986 Nov; 4(4):236-8. PubMed ID: 3797893
    [No Abstract]   [Full Text] [Related]  

  • 15. Experience with triple-drug therapy in a pharmacological erection program.
    Govier FE; McClure RD; Weissman RM; Gibbons RP; Pritchett TR; Kramer-Levien D
    J Urol; 1993 Dec; 150(6):1822-4. PubMed ID: 8230514
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Current role of intracavernous therapy in the treatment of erectile dysfunction].
    Asuar Aydillo S
    Arch Esp Urol; 2002 Jun; 55(5):475-82. PubMed ID: 12174413
    [No Abstract]   [Full Text] [Related]  

  • 17. Comparison of a mixture of papaverine, phentolamine and prostaglandin E1 with other intracavernous injections.
    Meinhardt W; Lycklama à Nijeholt AA; Kropman RF; Vermeij P; Zwartendijk J
    Eur Urol; 1994; 26(4):319-21. PubMed ID: 7713130
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Injection therapy for impotence.
    Kursh ED; Bodner DR; Resnick MI; Althof SE; Turner L; Risen C; Levine SB
    Urol Clin North Am; 1988 Nov; 15(4):625-9. PubMed ID: 3055615
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Diagnosis and therapy of erectile dysfunction using papaverine and phentolamine.
    Zentgraf M; Baccouche M; Jünemann KP
    Urol Int; 1988; 43(2):65-75. PubMed ID: 3291360
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Papaverine-induced priapism. Experiences with a new urologic emergency].
    Schneider AW; Busch R; Gonnermann D; Klosterhalfen H
    Dtsch Med Wochenschr; 1989 Feb; 114(6):214-7. PubMed ID: 2917481
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.